PKM2/PDK1 dual-targeted shikonin derivatives restore the sensitivity of EGFR-mutated NSCLC cells to gefitinib by remodeling glucose metabolism
- Resource Type
- Article
- Source
- In
European Journal of Medicinal Chemistry 5 March 2023 249 - Subject
- Language
- ISSN
- 0223-5234